All Stories

  1. Safety and efficacy of oral PCSK9 inhibitors in hypercholesterolemia: A systematic review and network meta-analysis
  2. Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies
  3. Impact of glucagon‐like peptide‐1 receptor agonism‐based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta‐analysis
  4. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis
  5. Parental birth weight as a predictor of neonatal and childhood outcomes in children: a systematic review and meta-analysis
  6. Glycemic control, weight-loss effects, and safety of cotadutide in individuals with type 2 diabetes: A systematic review and meta-analysis
  7. Impact of semaglutide use on glycemic and metabolic profile in adults with type 1 diabetes having overweight or obesity: A systematic review and meta-analysis
  8. Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh
  9. Cardiovascular Outcomes in Adults With Type 2 Diabetes Treated With Tirzepatide: A Systematic Review and Meta-Analysis of Real-World Studies
  10. Impact of traumatic brain injury severity on anterior pituitary function: A prospective study
  11. A young girl presented with short stature with Sprengel deformity: A case report
  12. Berardinelli–Seip congenital lipodystrophy: A rare case report
  13. Trabecular Bone Score in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis
  14. Metformin use & asthma outcomes in patients with concurrent diabetes & bronchial asthma: A systematic review & meta-analysis
  15. Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression
  16. Efficacy and Safety of Once-Weekly IcoSema in Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis
  17. Safety of esaxerenone (CS-3150) and its impacts on blood pressure and renal function: A systematic review and meta-analysis
  18. Impacts of Ramadan Fasting on Metabolic and Hepatic Endpoints in Individuals With Metabolic Dysfunction‐Associated Fatty Liver Disease: A Systematic Review and Meta‐Analysis
  19. Comparison of FIB-4, APRI and AST/ALT ratio with FibroScan in patients with NAFLD and type 2 diabetes: a single-center study from Bangladesh
  20. Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public Healthcare
  21. Thrice-Weekly Insulin Degludec Versus Once-Daily Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  22. Hypoglycaemia During Oral Glucose Tolerance Test in Pregnancy and Feto-Maternal Outcomes: A Systematic Review and Meta-Analysis
  23. One-hour vs Two-hour Postprandial Glucose Targets and Fetomaternal Outcomes in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
  24. Efficacy and Safety of Bexagliflozin, a Selective Sodium-Glucose Cotransporter-2 Inhibitor, in Type 2 Diabetes: A Systematic Review and Meta-Analysis
  25. Cardiovascular risk in newly diagnosed patients with type 2 diabetes mellitus: a nationwide, facility-based, cross-sectional study in Bangladesh
  26. Effect of beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review and meta-analysis
  27. Monogenic diabetes: An evidence-based clinical approach
  28. Neuropsychiatric Effects of Tirzepatide: A Systematic Review and Meta-Analysis
  29. Efficacy and Safety of Twincretin Survodutide, a Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist as an Anti-Obesity and Anti-Diabetes Medication: A Systematic Review and Meta-Analysis
  30. Reasons for discontinuing tirzepatide in randomized controlled trials: A systematic review and meta-analysis
  31. Optimal Use of Once-Weekly Basal Insulin Efsitora Alfa in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis
  32. Metabolic outcomes of bariatric surgery versus lifestyle intervention in adolescents with severe obesity: A systematic review and meta‐analysis
  33. Impact of 1-Year Tirzepatide Use on Glycemic and Metabolic Profile in Overweight to Obese People with Type 1 Diabetes: A Systematic Review and Meta-Analysis
  34. Once-Weekly Tirzepatide Versus Once-Daily Basal Insulin in Managing Type 2 Diabetes Inadequately Controlled With Oral anti-Hyperglycemic Drugs: A Systematic Review and Meta-Analysis
  35. Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis
  36. Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis
  37. Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study)
  38. Association of SIRT1 rs3758391 Polymorphism With T2DM in Bangladeshi Population: Evidence From a Case‐Control Study and Meta‐Analysis
  39. Approach to Endocrine Hypertension: A Case-Based Discussion
  40. Efficacy and Safety of Glucagon Like Peptide-1 Receptor Agonism Based Therapies in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis
  41. Efficacy and Safety of Early Initiation of Sodium–Glucose Co-transporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review and Meta-analysis
  42. Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
  43. Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  44. Efficacy and safety of the glucagon receptor antagonist volagidemab in type‐1 diabetes: A systematic review and meta‐analysis
  45. Pancreatic Safety of Tirzepatide and Its Effects on Islet Cell Function: A Systematic Review and Meta‐Analysis
  46. Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis
  47. Role of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
  48. Hormone replacement therapy for menopausal mood swings and sleep quality: The current evidence
  49. Reply to the Letter to the Editor, Endocrine Practice for "Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes: An Updated Systematic Review and Meta-Analysis”
  50. Glucose‐lowering drugs and liver‐related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population‐based studies
  51. Hepatobiliary effects and safety of tirzepatide: A systematic review and meta‐analysis
  52. Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis
  53. Demographic and Clinical Characteristics of Patients with Primary Hypothyroidism and Adequacy of Levothyroxine Replacement Therapy in Them: A Nationwide Study in Bangladesh
  54. Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
  55. Serum Magnesium and Glycemic Status in Newly Diagnosed T2DM Patients in Tertiary Care Hospital of Bangladesh
  56. Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis
  57. Bariatric surgery and tirzepatide—Friends, not foes!
  58. Role of Resmetirom, a Liver-Directed, Thyroid Hormone Receptor Beta-Selective Agonist, in Managing Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
  59. Role of Growth Hormone Therapy in Metabolic-Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
  60. Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: A systematic review and meta-analysis
  61. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis
  62. First-trimester fasting plasma glucose as a predictor of subsequent gestational diabetes mellitus and adverse fetomaternal outcomes: A systematic review and meta-analysis
  63. Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes: An Updated Systematic Review and Meta-Analysis
  64. Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study)
  65. Metabolic association of serum prolactin in polycystic ovary syndrome: A retrospective analysis of 840 patients in Bangladesh
  66. Global Warming and Endocrinology: The Hyderabad Declaration of the South Asian Federation of Endocrine Societies
  67. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  68. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  69. Orforglipron, a novel non‐peptide oral daily glucagon‐like peptide‐1 receptor agonist as an anti‐obesity medicine: A systematic review and meta‐analysis
  70. Acute hypothermia in a patient with COVID-19: a case report and summary of the evidence
  71. Approach to management of hypo and hyperthyroidism in Bangladesh: a nationwide physicians’ perspective survey
  72. Efficacy and Safety of Ertugliflozin Compared to Placebo in Patients With Type 2 Diabetes: An Updated Systematic Review and Meta‐Analysis
  73. Approach to a Patient with Discordant Thyroid Function
  74. Comparative Analysis of Metformin and Imeglimin: Exploring Therapeutic Implications
  75. Role of Chia Seed (Salvia hispanica L.) Supplements in Managing Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
  76. Safety and Efficacy of Semaglutide Use in Diabetes during Ramadan Fasting: A Real-world Experience from Bangladesh
  77. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study
  78. Prevalence and patterns of dyslipidemia among lipid-lowering drug-naïve patients with type 2 diabetes mellitus – A countrywide study in Bangladesh
  79. Effect of Moringa oleifera Leaf Extract on Glycemic Parameters in Patients with Type 2 Diabetes Mellitus and Prediabetes: A Systematic Review and Meta-analysis
  80. Comparison of fasting and random lipid profiles among subjects with type 2 diabetes mellitus: an outpatient-based cross-sectional study in Bangladesh
  81. Fasting with diabetes during Ramadan: An updated review
  82. Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: The DAR-BAN study
  83. Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh
  84. Clinical and hormonal profile of polycystic ovary syndrome phenotypes: An observational study at a tertiary care hospital in Bangladesh
  85. Sexual dysfunction in women with type 2 diabetes mellitus: A single-centre cross-sectional study from Bangladesh
  86. Male infertility in diabetes mellitus: An insight into the pathophysiology
  87. Nonalcoholic fatty liver disease in polycystic ovary syndrome: Result of a single-center cross-sectional study in Bangladesh
  88. Thyroid disorders in bangladesh: An epidemiological perspective
  89. Bangladesh endocrine society guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum
  90. Comparison of Vitamin D Status between Resident and Nonresident Bangladeshis with Type 2 Diabetes Mellitus: A Single-Center, Cross-Sectional Study
  91. Coexistent papillary thyroid carcinoma in a patient with graves' disease
  92. Prevalence and characteristics of women with polycystic ovary syndrome in Bangladesh – A narrative review
  93. Hypocalcemic Seizures in Infancy and its Relationship with Maternal Vitamin D Deficiency
  94. Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh
  95. Comparison of Serum Vitamin B12 Levels Among Drug-Naïve and Metformin-Treated Patients With Polycystic Ovary Syndrome
  96. Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh
  97. Serum Zinc Level and Glycemic Status in Newly Diagnosed Type 2 Diabetes Mellitus Patients in a Tertiary Care Hospital of Bangladesh
  98. Comparison of Fasting and Random Lipid Profile among Subjects with Type-2 Diabetes Mellitus Patients: An Outpatient-Based Cross-Sectional Study in Bangladesh
  99. Prevalence and predictors of diabetes distress among adults with type 2 diabetes mellitus: a facility-based cross-sectional study of Bangladesh
  100. A 27-year-old man with rare genetic disorder presented with morbid obesity
  101. Advanced polyostotic fibrous dysplasia
  102. Subtype and severity of stroke at presentation in subjects with and without type 2 diabetes
  103. Precocious puberty: diagnosis and management
  104. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease
  105. Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
  106. Comparison of clinical, metabolic, and hormonal parameters in lean vs. obese women with polycystic ovary syndrome: a single-center study from Bangladesh
  107. Correlation of serum amylase level with the severity of acute organophosphorus compounds poisoning
  108. Serum thyroglobulin level in newly detected thyrotoxicosis and its role in differential diagnosis of thyrotoxicosis
  109. Neck circumference as a predictor of obesity and metabolic syndrome in bangladeshi women with polycystic ovary syndrome
  110. Demographic, Clinical and Biochemical Characteristics of Drug Naive Type 2 Diabetes Patients of Bangladesh
  111. Serum vitamin B12 status of patients with type 2 diabetes mellitus on metformin: A single-center cross-sectional study from Bangladesh
  112. Evaluation of Chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus–related compensated chronic liver disease
  113. Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome
  114. Evaluation of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as markers of diabetic kidney disease in Bangladeshi patients with type 2 diabetes mellitus
  115. Management of Diabetes in Pregnancy During COVID-19 Pandemic
  116. Comparison of risk factors, management and outcome between early and lately detected gestational diabetes mellitus patients
  117. Serum uric acid level in Bangladeshi adults with essential hypertension
  118. Frequency and correlates of comorbid depression in polycystic ovary syndrome
  119. Insulin Injection Practice and Injection Complications – Results from the Bangladesh Insulin Injection Technique Survey
  120. Vitamin D status of overweight and obese Bangladeshi adults
  121. Prevalence of thyroid dysfunction and thyroid autoimmunity in polycystic ovary syndrome: A multicenter study from Bangladesh
  122. Comparison of the nonfasting and fasting lipid profiles of the patients admitted in the cardiology department of a tertiary hospital in Bangladesh
  123. Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome – A Cross-sectional Study from Bangladesh
  124. Predisposing factors of hypoglycemia in patients with type 2 diabetes mellitus presented with symptomatic hypoglycemia in a tertiary hospital of Bangladesh
  125. Divergences in Clinical, Anthropometric, Metabolic, and Hormonal Parameters among Different Phenotypes of Polycystic Ovary Syndrome Presenting at Endocrinology Outpatient Departments: A Multicenter Study from Bangladesh
  126. Knowledge and Practice of Physicians to Hyperglycemia in Pregnancy: A Nationwide Survey in Bangladesh
  127. Serum c-peptide level in newly diagnosed Bangladeshi adults with type 2 diabetes mellitus
  128. Circadian variation in stroke: a hospital-based study
  129. Seroprevalence of Hepatitis B and Hepatitis C in end-stage renal disease patients on maintenance hemodialysis: a single-center study from Bangladesh
  130. Frequency and predictors of hyperglycemia in patients with various thyroid disorders attending a tertiary hospital of Bangladesh
  131. Serum magnesium status and its correlation with insulin resistance in newly diagnosed patients with type 2 diabetes mellitus
  132. Vitamin D Status in Primary Hypothyroid Subjects Attending a Specialized Endocrine Center of Bangladesh
  133. Short-Term Weight Changes in Treated Primary Hypothyroid Subjects
  134. Iodine nutrition status in Graves' disease: A single-center study from Bangladesh
  135. Effect of Intravenous Methylprednisolone on the Signs & Symptoms of Graves’ Ophthalmopathy
  136. Thyroid function and autoantibody status in Bangladeshi patients with type 2 diabetes mellitus
  137. Impact of iodine nutrition status on thyroid autoimmunity in subclinical hypothyroid patients attending a tertiary hospital of Bangladesh
  138. Serum Ferritin in Newly Detected Diabetes and Prediabetes
  139. Vitamin B12 is Found Sufficient in Newly Diagnosed Type 2 Diabetes in a Hospital Based Study